← Back to Search

Smartphone vs In-Person Training for Quitting Smoking

N/A

Waitlist Available

Led By Eve Nagler, ScD, MPH

Research Sponsored by Harvard School of Public Health (HSPH)

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and immediate post intervention

Awards & highlights

Study Summary

This trial will compare the effectiveness of in-person vs smartphone-based training for a tobacco-free program in India.

Who is the study for?

This trial is for teachers and principals currently working in schools within the Indian state of Madhya Pradesh. There are no specific exclusion criteria, meaning all educators in this region can participate regardless of their smoking status or other factors.Check my eligibility

What is being tested?

The study is testing two methods to deliver a tobacco control program: one group receives training through a smartphone app, while another gets it face-to-face. The goal is to see which method helps more educators quit smoking and how well each approach works overall.See study design

What are the potential side effects?

Since this trial involves educational training rather than medical treatment, there aren't typical side effects like with drugs or surgery. However, participants may experience stress or time constraints due to involvement in the program.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and immediate post intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and immediate post intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and immediate post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Tobacco use cessation among teachers

Trial Design

2Treatment groups

Experimental Treatment

Group I: Smart phone based trainingExperimental Treatment1 Intervention

Smartphone-based training for Headmasters to implement the Tobacco Free Teachers-Tobacco Free Society program in their schools in Madhya Pradesh, India

Group II: In person trainingExperimental Treatment1 Intervention

In person training for Headmasters to implement the Tobacco Free Teachers-Tobacco Free Society program in their schools in Madhya Pradesh, India

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Harvard School of Public Health (HSPH)Lead Sponsor

272 Previous Clinical Trials

16,303,202 Total Patients Enrolled

Healis-Sekhsaria Institute for Public HealthOTHER

3 Previous Clinical Trials

8,927 Total Patients Enrolled

Eve Nagler, ScD, MPHPrincipal InvestigatorDana-Farber Cancer Institute

Media Library

In person training Clinical Trial Eligibility Overview. Trial Name: NCT05500235 — N/A

Quitting Smoking Research Study Groups: Smart phone based training, In person training

Quitting Smoking Clinical Trial 2023: In person training Highlights & Side Effects. Trial Name: NCT05500235 — N/A

In person training 2023 Treatment Timeline for Medical Study. Trial Name: NCT05500235 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment phase of this research currently open?

"Data published on clinicaltrials.gov indicates that this research trial is no longer recruiting participants, as the last update was provided in August of 2022. Although there are 23 separate studies presently accepting patients at this time, unfortunately this study has closed its registration process."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Comparing Smartphone to In-person Training to Scale up a Tobacco Control Program for Teachers in India

Eve Nagler 2023. "Comparing Smartphone to In-person Training to Scale up a Tobacco Control Program for Teachers in India". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05500235.